Corcept Therapeutics CORT
NASDAQ CORT
$114.74 -0.89 (-0.77%)
At close: Sep 29, 2026 · 4:00 PM EDT

Corcept Therapeutics (CORT) Share-based Compensation (2010 - 2026)

Updated

Corcept Therapeutics (CORT) recorded Share-based Compensation of $29.42 million in Q2 2026, up 54.6% from $19.02 million a year earlier and up 27.7% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Share-based Compensation (2010 - 2026) Analysis & Trends

On a TTM basis, Corcept Therapeutics' Share-based Compensation came in at $96.11 million as of Jun 30, 2026, up 30.3% year-over-year; for FY2025, it was $84.5 million, up 37.7% from FY2024.

  • Annual Share-based Compensation has increased for three straight years, with a five-year compound annual growth rate of 20.3% (FY2020 to FY2025).
  • Across earlier years, Share-based Compensation came in at $61.35 million in FY2024 (+25.4%), $48.94 million in FY2023 (+15.3%), $42.44 million in FY2022 (-1.1%) and $42.93 million in FY2021 (+28.0%).
  • The Q2 2026 figure is the highest quarterly Share-based Compensation in data going back to Q3 2010.
  • On a year-over-year basis, Share-based Compensation has increased for 14 consecutive quarters, with growth averaging 33.7% over the last eight quarters.
  • Peak year-over-year performance for Share-based Compensation in the last five years was growth of 64.8% in Q1 2025, against a decline of 4.2% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $23.04 million (Q1 2026), $20.77 million (Q4 2025) and $22.88 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Corcept Therapeutics 12.50 Bn 11.06 Bn 252.09 Mn 29.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.42 Mn
Mar 31, 2026 23.04 Mn
Dec 31, 2025 20.77 Mn
Sep 30, 2025 22.88 Mn
Jun 30, 2025 19.02 Mn
Mar 31, 2025 21.83 Mn
Dec 31, 2024 16.80 Mn
Sep 30, 2024 16.10 Mn
Jun 30, 2024 15.21 Mn
Mar 31, 2024 13.25 Mn
Dec 31, 2023 13.07 Mn
Sep 30, 2023 12.88 Mn
Jun 30, 2023 11.86 Mn
Mar 31, 2023 11.14 Mn
Dec 31, 2022 10.52 Mn
Sep 30, 2022 10.55 Mn
Jun 30, 2022 10.61 Mn
Mar 31, 2022 10.76 Mn
Dec 31, 2021 10.81 Mn
Sep 30, 2021 10.95 Mn
API Access

Corcept Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CORT&period=max&api_key=YOUR_API_KEY